vTv Therapeutics (VTVT) EBIT Margin (2014 - 2026)
vTv Therapeutics (VTVT) reported EBIT Margin of 63.15% for Q1 2026, up 100.22% sequentially from 28776.47% in Q4 2024.
vTv Therapeutics (VTVT) EBIT Margin (2014 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 11 years of EBIT Margin data on file, last reported at 63.15% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin changed N/A year-over-year to 63.15%; the trailing twelve-month figure through Mar 2026 stood at 8.26% (up 14737998.0% YoY), and the FY2024 full-year result was 2377.58%, changed N/A from the prior year.
- EBIT Margin rose to 63.15% in Q1 2026, from 28776.47% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 63.15% in Q1 2026 to a low of 70477.78% in Q4 2022.
- A 3-year average of 24137.05% and a median of 14669.59% in 2024 frame the typical range for EBIT Margin.
- Peak annual rise in EBIT Margin reached 5295556 bps in 2022, while the deepest fall reached 10959 bps in 2022.
- Tracing VTVT's EBIT Margin over 3 years: stood at 70477.78% in 2022, then surged by 59 bps to 28776.47% in 2024, then surged by 100 bps to 63.15% in 2026.
- Business Quant data shows VTVT's EBIT Margin at 63.15% in Q1 2026, 28776.47% in Q4 2024, and 562.7% in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | 63.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.15% |
| Dec 31, 2024 | -28,776.47% |
| Mar 31, 2024 | -562.70% |
| Dec 31, 2022 | -70,477.78% |
| Jun 30, 2022 | -44,744.44% |
| Mar 31, 2022 | -324.05% |
| Dec 31, 2021 | -123,433.33% |
| Sep 30, 2021 | -53.43% |
| Jun 30, 2021 | -51,888.89% |
| Mar 31, 2021 | -433.64% |
| Dec 31, 2020 | 28.60% |
| Sep 30, 2020 | -40,457.14% |
| Mar 31, 2020 | -83,075.00% |
| Dec 31, 2019 | -91,257.14% |
| Sep 30, 2019 | -67,812.50% |
| Jun 30, 2019 | -262.14% |
| Mar 31, 2019 | -465.47% |
| Dec 31, 2018 | -7.76% |
| Sep 30, 2018 | -43.88% |
| Jun 30, 2018 | -358.19% |